KIM COX: Open Payments
NPI 1326131434 · BOONEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 52 payments from 13 companies in 2025. Trend: 2023 $319 · 2024 $901 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $364 |
| Janssen Pharmaceuticals, Inc | 4 | $170 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| MIMEDX Group, Inc. | 2 | $88 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Indivior Inc. | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Braeburn Inc. | 2 | $28 |
Products named: VRAYLAR, SPRAVATO, Auvelity, FYCOMPA, CAPLYTA, QULIPTA, FANAPT, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
